Patent application number | Description | Published |
20100077654 | SYSTEMS AND METHODS FOR PRODUCING BIOFUELS FROM ALGAE - The invention provides systems and methods for producing biofuel from algae wherein the algae and fishes are co-cultured in a body of water. The methods further comprise inducing the algae to accumulate lipids by environmental stress, and concentrating the algae prior to extraction of the algal oil. The systems of the invention comprise at least one growth enclosure, means for concentrating algae, and means for subjecting algae to environmental stress. | 04-01-2010 |
20100081835 | SYSTEMS AND METHODS FOR PRODUCING BIOFUELS FROM ALGAE - The invention provides systems and methods for producing biofuel from algae that use cultured fish to harvest algae from an algal culture. The methods further comprise gathering the fish, extracting lipids from the fish, and processing the lipids to form biofuel. The multi-trophic systems of the invention comprises at least one enclosure that contains the algae and the fishes, and means for controllably feeding the algae to the fishes. The lipid compositions extracted from the fishes are also encompassed. | 04-01-2010 |
20100236137 | SYSTEMS AND METHODS FOR PRODUCING EICOSAPENTAENOIC ACID AND DOCOSAHEXAENOIC ACID FROM ALGAE - Provided herein are systems and methods for producing eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) and/or derivatives and/or mixtures thereof by growing algae that produce the oils containing EPA and/or DHA and/or derivatives and/or mixtures thereof, harvesting the algae with fish in one or more enclosed systems, and then processing fish to separate and purify the EPA and/or DHA. The multi-trophic systems provided herein comprise at least one enclosure that contains the algae and the fishes, and means for controllably feeding the algae to the fishes. Also provided herein are the lipid compositions extracted from the fishes. | 09-23-2010 |
20110239318 | METHODS FOR PRODUCING FISH WITH HIGH LIPID CONTENT - The invention provides methods for producing biofuel from algae, that use fish which have a high capacity of producing and/or accumulating lipids to harvest algae from an algal culture. The invention also provides methods for growing fish that result in a high lipid content. The invention also provides methods for creating fish that have a high capacity of producing and accumulating lipids by breeding and/or recombinant DNA techniques. Also included are transgenic fish that have a higher lipid content than wild-type fish. | 09-29-2011 |
20120058248 | SYSTEMS AND METHODS FOR REDUCING ALGAL BIOMASS - The invention relates to systems and methods for reducing algal biomass in eutrophic water, wherein organism that feed on algae are introduced into the eutrophic water and cultured in the eutrophic water, until the algal biomass is reduced or the organisms have reach desirable size. The body of eutrophic water can be restocked with juveniles after harvesting. The organisms can be fishes and/or shellfishes. The methods further comprising producing biofuel, specialty chemicals, nutraceuticals, food, and/or fish meal from the harvested fish. | 03-08-2012 |
20120058542 | SYSTEMS AND METHODS FOR REGULATING ALGAL BIOMASS - The invention relates to systems and methods for regulating algal biomass in offshore waters near an oil and gas production platform. The systems of the invention encompasses a plurality of modules for managing nutrients, algae, and aquaculture, including enclosures for containing aquatic organisms, and various operating subsystems that are operably associated with surface and underwater structures of the platform. In one embodiment of the invention, aquatic organisms are cultured in eutrophic water to feed on algae, thereby reducing the algal biomass. In other embodiments, the diversity of algae in an algal bloom is modified and the productivity of oligotrophic water is increased. | 03-08-2012 |
20120137574 | SYSTEMS AND METHODS FOR HARVESTING ALGAE - Provided herein are systems and methods for producing biofuel from microalgae that use a population of zooplankton to harvest microalgae in a culture. The methods further comprise gathering the zooplankton, extracting lipids from the zooplankton, and processing the lipids to form biofuel. The systems provided herein comprise at least one enclosure comprising microalgae, means for making the microalgae available to a population of zooplankton, and means for gathering the zooplankton. | 06-07-2012 |
20120231513 | SYSTEMS AND METHODS FOR CULTURING ALGAE WITH BIVALVES - Provided herein are systems and methods for extracting lipids and/or producing biofuel from algae in marine and freshwater environments, wherein algae and bivalves are co-cultured in a system of enclosures comprising water that comprises recycled nutrients that are essential for algal growth. The system also include enclosures for culturing fishes which are used to harvest the algae. | 09-13-2012 |
20120277449 | SYSTEMS AND METHODS FOR PRODUCING BIOFUELS FROM ALGAE - Provided herein are systems and methods for producing fish lipids and/or biofuels from algae that use nutrient-πch water derived from an upwelled water. The methods comprise harvesting the algae by a population of planktivorous organisms, such as fishes, gathering the planktivorous organisms, and extracting lipids from the organisms and/or polishing the lipids to form biofuel. | 11-01-2012 |
20120283458 | SOURCING PHOSPHORUS AND OTHER NUTRIENTS FROM THE OCEAN VIA OCEAN THERMAL ENERGY CONVERSION SYSTEMS - Provided herein are controlled methods for producing biofuel and lipids from algae. In certain embodiments, the controlled methods comprise: (i) providing upwelled water in a body of water; (ii) culturing algae in the upwelled water; (iii) feeding the algae to planktivorious organisms; (iv) extracting lipids from the planktivorious organisms; and (v) polishing the lipids to make biofuel or other useful products. In certain embodiments, the upwelled water is provided in the body of water by using an open-cycle OTEC system. Also provided herein are controlled systems for producing biofuel and lipids from algae. | 11-08-2012 |
20120284165 | METHOD FOR REMOVING CARBON DIOXIDE FROM OCEAN WATER AND QUANTIFYING THE CARBON DIOXIDE SO REMOVED - Disclosed herein are methods and systems for removing carbon dioxide (CO | 11-08-2012 |
20120285392 | DEEP WATER NUTRIENT RECOVERY SYSTEM - Disclosed herein are methods for mixing of carbon dioxide (CO | 11-15-2012 |
20140220664 | Systems and Methods for Culturing Algae With Bivalves - Provided herein are systems and methods for extracting lipids and/or producing biofuel from algae in marine and freshwater environments, wherein algae and bivalves are co-cultured in a system of enclosures comprising water that comprises recycled nutrients that are essential for algal growth. The system also include enclosures for culturing fishes which are used to harvest the algae. | 08-07-2014 |
20150056672 | SYSTEMS AND METHODS FOR PRODUCING EICOSAPENTAENOIC ACID AND DOCOSAHEXAENOIC ACID FROM ALGAE - Provided herein are systems and methods for producing eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) and/or derivatives and/or mixtures thereof by growing algae that produce the oils containing EPA and/or DHA and/or derivatives and/or mixtures thereof, harvesting the algae with fish in one or more enclosed systems, and then processing fish to separate and purify the EPA and/or DHA. The multi-trophic systems provided herein comprise at least one enclosure that contains the algae and the fishes, and means for controllably feeding the algae to the fishes. Also provided herein are the lipid compositions extracted from the fishes. | 02-26-2015 |
Patent application number | Description | Published |
20090011431 | Diagnosis of Sepsis by the Selective Determination of the Concentration of Cu/Zn Superoxide Dismutase (Cu/Zn Sod) in Patient Samples - The present invention relates to a method for the early determination of the risk of mortality of patients in intensive care units or emergency care units during which the concentration of Cu/Zn superoxide dismutase (Cu/Zn SOD) in a serum sample or plasma sample of the patient is selectively determined, and quantitatively or semi-quantitatively measured concentrations, which exceed a predetermined threshold value are correlated with a high risk of mortality. | 01-08-2009 |
20090012268 | NOVEL MONOCLONAL THYROID STIMULATING OR BLOCKING ANTIBODIES, PEPTIDE SEQUENCES CORRESPONDING TO THEIR VARIABLE REGIONS, AND THEIR USES IN DIAGNOSTIC, PREVENTIVE AND THERAPEUTIC MEDICINE - Monoclonal antibodies (mAbs) having thyroid stimulating activity (TSAb), especially full or considerably agonistic activity, or thyroid blocking activity (TBAb), which are obtainable by genetic immunization of mice, or fragments (F(ab′) | 01-08-2009 |
20090176267 | IN VITRO METHOD FOR THE IDENTIFICATION AND EARLY IDENTIFICATION AND FOR THE CONCOMITANT MONITORING OF THE THERAPY OF DRUG-AND ADDICTIVE SUBSTANCE-INDUCED LIVER DAMAGE - Disclosed is an in vitro method for the identification and the concomitant monitoring of the therapy and cure of drug-induced or addictive substance-induced liver damage, in which the occurrence of the human enzyme carbamoyl synthase 1 (CPS 1) or its concentration is determined in serum or plasma samples from patients who are being or have been treated with potentially liver-damaging drugs, or from people who take harmful stimulants and addictive substances or are exposed to hepatotoxic substances. | 07-09-2009 |
20090191220 | METHODS FOR THE DIAGNOSIS AND TREATMENT OF CRITICALLY ILL PATIENTS WITH ENDOTHELIN, ENDOTHELIN AGONISTS AND ADRENOMEDULLIN ANTAGONISTS - The ratio of concentrations of pro-adrenomedullin (pro-ADM)/pro-endothelin (pro-END) immunoreactivity in body fluids of critically ill patients is used as for the diagnosis, course control and prognosis, including an assessment of the mortality risk, of severe life threatening diseases. Further, a treatment of critically ill patients having high levels of pro-ADM but insufficient levels of pro-END immunoreactivities with a medicament comprising vasoconstrictive endothelin or its precursors, and/or endothelin agonists or adrenomedullin antagonists is provided. | 07-30-2009 |
20100209433 | METHODS FOR THE DIAGNOSIS AND FOR THE TREATMENT OF CRITICALLY ILL PATIENTS WITH ENDOTHELIN, ENDOTHELIN AGONISTS AND ADRENOMEDULLIN ANTAGONISTS - The ratio of concentrations of pro-adrenomedullin (pro-ADM)/pro-endothelin (pro-END) immunoreactivity in body fluids of critically ill patients is used for the diagnosis, course control and prognosis, including an assessment of the mortality risk, of severe life threatening diseases. Further, a treatment of critically ill patients having high levels of pro-ADM but insufficient levels of pro-END immunoreactivities with a medicament comprising vasoconstrictive endothelin or its precursors, and/or endothelin agonists or adrenomedullin antagonists is provided. | 08-19-2010 |
20120122233 | METHOD FOR RISK STRATIFICATION IN STABLE CORONARY ARTERY DISEASE - An in vitro method for the risk stratification of patients with stable arteriosclerosis, especially stable coronary artery disease, is disclosed wherein the concentration of procalcitonin is determined in the circulation of such patients using a highly sensitive PCT assay, and wherein within the range of PCT concentrations in the typical normal range of healthy individuals cutoff values are defined which distinguish groups of individual patients with stable arteriosclerosis in accordance with personal cardiac risk, and patients are allotted to one of said risk groups on the basis of their individual PCT concentrations. | 05-17-2012 |
20150087727 | METHOD FOR RISK STRATIFICATION IN STABLE CORONARY ARTERY DISEASE - An in vitro method for the risk stratification of patients with stable arteriosclerosis, especially stable coronary artery disease, is disclosed wherein the concentration of procalcitonin is determined in the circulation of such patients using a highly sensitive PCT assay, and wherein within the range of PCT concentrations in the typical normal range of healthy individuals cutoff values are defined which distinguish groups of individual patients with stable arteriosclerosis in accordance with personal cardiac risk, and patients are allotted to one of said risk groups on the basis of their individual PCT concentrations. | 03-26-2015 |